2.1K
Downloads
12
Episodes
Welcome to the Canadian Heart Failure Society (CHFS) podcast channel. The CHFS provides a forum for cardiovascular professionals to exchange ideas, advance knowledge, improve practice and care delivery in the prevention, diagnosis, and management of all Heart Failure phases and complications. Visit https://heartfailure.ca/ to learn more.
Episodes
Wednesday Jun 16, 2021
Wednesday Jun 16, 2021
In this episode, Dr. Stephanie Poon, Cardiologist at Sunnybrook Health Sciences Centre and Medical Co-Director of the Heart Function and Rapid Cardiology Assessment Clinic, and Dr. Sean Virani, Cardiologist at Providence Health Care and St. Paul’s Hospital, and Co-Chair of the 2021 CCS/CHFS Heart Failure Guidelines, discuss the current state of heart failure care in Canada. Dr. Poon talks about some of the findings from the Canadian Cardiovascular Society National Quality Project. They discuss quality indicators such as the 30-day readmission rate, length of stay and timing of hospital discharge, and whether there have been some changes over the last decade. Dr. Virani talks about the CAN-HF Registry which looks at patients who are hospitalized as well as patients in the ambulatory visits to see if they are treated as per guideline-directed medical therapy and the impact on patient outcomes.
For more information and resources, visit the Canadian Heart Failure Website at www.heartfailure.ca
This program is made possible through funding from Novartis Canada.
Wednesday Jun 16, 2021
Wednesday Jun 16, 2021
In this episode, Dr. James Januzzi, Hutter Family Professor of Medicine at Harvard Medical School and cardiologist at the Massachusetts General Hospital in Boston, discusses with Dr. Shelley Zieroth, Cardiologist at St. Boniface Hospital in Winnipeg, Manitoba and the Immediate Past President of the Canadian Heart Failure Society. Dr. Zieroth and Dr. Januzzi discuss the 2021 updates to the ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment as well as the 2021 CCS/CHFS Heart Failure Guidelines Update. They discuss emerging evidence that support the treatment of HFrEF with 4 standard therapies: ARNI, Beta Blocker, MRA and SGLT2is. They end their conversation with an important message on the way healthcare professionals can advise their patients on how these comprehensive therapies can help them live longer and improve their quality of life.
For more information and resources, visit the Canadian Heart Failure Website at www.heartfailure.ca
This program is made possible through funding from Novartis Canada.